CLINICAL_TRIALS
trial_result
· 2025-03-30
Clinical Trial Update: A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis [Phase 3]
Summary
A long-term Phase 3 trial of OPA-15406 in infants with atopic dermatitis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Atopic Dermatitis (AD) | Phase 3 | Status: COMPLETED | Results posted: 2025-03-30